[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Newborn Genetic Screening Supply, Demand and Key Producers, 2023-2029

February 2023 | 111 pages | ID: GE59C1845F59EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Newborn Genetic Screening market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Newborn Genetic Screening demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Newborn Genetic Screening, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Newborn Genetic Screening that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Newborn Genetic Screening total market, 2018-2029, (USD Million)

Global Newborn Genetic Screening total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Newborn Genetic Screening total market, key domestic companies and share, (USD Million)

Global Newborn Genetic Screening revenue by player and market share 2018-2023, (USD Million)

Global Newborn Genetic Screening total market by Type, CAGR, 2018-2029, (USD Million)

Global Newborn Genetic Screening total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Newborn Genetic Screening market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Trivitron Healthcare, MASIMO CORPORATION, Covidien Plc, Nemours KidsHealth, NJ.gov, Agilent Technologies, Ge Healthcare, PERKINELMER and Natus Medical Incorporated, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Newborn Genetic Screening market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Newborn Genetic Screening Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Newborn Genetic Screening Market, Segmentation by Type
  • Dry blood spot tests
  • Hearing screening tests
  • CCHD screening tests
Global Newborn Genetic Screening Market, Segmentation by Application
  • Clinical Laboratories
  • Hospitals
Companies Profiled:
  • Trivitron Healthcare
  • MASIMO CORPORATION
  • Covidien Plc
  • Nemours KidsHealth
  • NJ.gov
  • Agilent Technologies
  • Ge Healthcare
  • PERKINELMER
  • Natus Medical Incorporated
  • Waters
  • Bio-Rad Laboratories
  • Ab Sciex LLC
Key Questions Answered

1. How big is the global Newborn Genetic Screening market?

2. What is the demand of the global Newborn Genetic Screening market?

3. What is the year over year growth of the global Newborn Genetic Screening market?

4. What is the total value of the global Newborn Genetic Screening market?

5. Who are the major players in the global Newborn Genetic Screening market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Newborn Genetic Screening Introduction
1.2 World Newborn Genetic Screening Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Newborn Genetic Screening Total Market by Region (by Headquarter Location)
  1.3.1 World Newborn Genetic Screening Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Newborn Genetic Screening Market Size (2018-2029)
  1.3.3 China Newborn Genetic Screening Market Size (2018-2029)
  1.3.4 Europe Newborn Genetic Screening Market Size (2018-2029)
  1.3.5 Japan Newborn Genetic Screening Market Size (2018-2029)
  1.3.6 South Korea Newborn Genetic Screening Market Size (2018-2029)
  1.3.7 ASEAN Newborn Genetic Screening Market Size (2018-2029)
  1.3.8 India Newborn Genetic Screening Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Newborn Genetic Screening Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Newborn Genetic Screening Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Newborn Genetic Screening Consumption Value (2018-2029)
2.2 World Newborn Genetic Screening Consumption Value by Region
  2.2.1 World Newborn Genetic Screening Consumption Value by Region (2018-2023)
  2.2.2 World Newborn Genetic Screening Consumption Value Forecast by Region (2024-2029)
2.3 United States Newborn Genetic Screening Consumption Value (2018-2029)
2.4 China Newborn Genetic Screening Consumption Value (2018-2029)
2.5 Europe Newborn Genetic Screening Consumption Value (2018-2029)
2.6 Japan Newborn Genetic Screening Consumption Value (2018-2029)
2.7 South Korea Newborn Genetic Screening Consumption Value (2018-2029)
2.8 ASEAN Newborn Genetic Screening Consumption Value (2018-2029)
2.9 India Newborn Genetic Screening Consumption Value (2018-2029)

3 WORLD NEWBORN GENETIC SCREENING COMPANIES COMPETITIVE ANALYSIS

3.1 World Newborn Genetic Screening Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Newborn Genetic Screening Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Newborn Genetic Screening in 2022
  3.2.3 Global Concentration Ratios (CR8) for Newborn Genetic Screening in 2022
3.3 Newborn Genetic Screening Company Evaluation Quadrant
3.4 Newborn Genetic Screening Market: Overall Company Footprint Analysis
  3.4.1 Newborn Genetic Screening Market: Region Footprint
  3.4.2 Newborn Genetic Screening Market: Company Product Type Footprint
  3.4.3 Newborn Genetic Screening Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Newborn Genetic Screening Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Newborn Genetic Screening Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Newborn Genetic Screening Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Newborn Genetic Screening Consumption Value Comparison
  4.2.1 United States VS China: Newborn Genetic Screening Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Newborn Genetic Screening Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Newborn Genetic Screening Companies and Market Share, 2018-2023
  4.3.1 United States Based Newborn Genetic Screening Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Newborn Genetic Screening Revenue, (2018-2023)
4.4 China Based Companies Newborn Genetic Screening Revenue and Market Share, 2018-2023
  4.4.1 China Based Newborn Genetic Screening Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Newborn Genetic Screening Revenue, (2018-2023)
4.5 Rest of World Based Newborn Genetic Screening Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Newborn Genetic Screening Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Newborn Genetic Screening Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Newborn Genetic Screening Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Dry blood spot tests
  5.2.2 Hearing screening tests
  5.2.3 CCHD screening tests
5.3 Market Segment by Type
  5.3.1 World Newborn Genetic Screening Market Size by Type (2018-2023)
  5.3.2 World Newborn Genetic Screening Market Size by Type (2024-2029)
  5.3.3 World Newborn Genetic Screening Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Newborn Genetic Screening Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Clinical Laboratories
  6.2.2 Hospitals
6.3 Market Segment by Application
  6.3.1 World Newborn Genetic Screening Market Size by Application (2018-2023)
  6.3.2 World Newborn Genetic Screening Market Size by Application (2024-2029)
  6.3.3 World Newborn Genetic Screening Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Trivitron Healthcare
  7.1.1 Trivitron Healthcare Details
  7.1.2 Trivitron Healthcare Major Business
  7.1.3 Trivitron Healthcare Newborn Genetic Screening Product and Services
  7.1.4 Trivitron Healthcare Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Trivitron Healthcare Recent Developments/Updates
  7.1.6 Trivitron Healthcare Competitive Strengths & Weaknesses
7.2 MASIMO CORPORATION
  7.2.1 MASIMO CORPORATION Details
  7.2.2 MASIMO CORPORATION Major Business
  7.2.3 MASIMO CORPORATION Newborn Genetic Screening Product and Services
  7.2.4 MASIMO CORPORATION Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 MASIMO CORPORATION Recent Developments/Updates
  7.2.6 MASIMO CORPORATION Competitive Strengths & Weaknesses
7.3 Covidien Plc
  7.3.1 Covidien Plc Details
  7.3.2 Covidien Plc Major Business
  7.3.3 Covidien Plc Newborn Genetic Screening Product and Services
  7.3.4 Covidien Plc Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Covidien Plc Recent Developments/Updates
  7.3.6 Covidien Plc Competitive Strengths & Weaknesses
7.4 Nemours KidsHealth
  7.4.1 Nemours KidsHealth Details
  7.4.2 Nemours KidsHealth Major Business
  7.4.3 Nemours KidsHealth Newborn Genetic Screening Product and Services
  7.4.4 Nemours KidsHealth Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Nemours KidsHealth Recent Developments/Updates
  7.4.6 Nemours KidsHealth Competitive Strengths & Weaknesses
7.5 NJ.gov
  7.5.1 NJ.gov Details
  7.5.2 NJ.gov Major Business
  7.5.3 NJ.gov Newborn Genetic Screening Product and Services
  7.5.4 NJ.gov Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 NJ.gov Recent Developments/Updates
  7.5.6 NJ.gov Competitive Strengths & Weaknesses
7.6 Agilent Technologies
  7.6.1 Agilent Technologies Details
  7.6.2 Agilent Technologies Major Business
  7.6.3 Agilent Technologies Newborn Genetic Screening Product and Services
  7.6.4 Agilent Technologies Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Agilent Technologies Recent Developments/Updates
  7.6.6 Agilent Technologies Competitive Strengths & Weaknesses
7.7 Ge Healthcare
  7.7.1 Ge Healthcare Details
  7.7.2 Ge Healthcare Major Business
  7.7.3 Ge Healthcare Newborn Genetic Screening Product and Services
  7.7.4 Ge Healthcare Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Ge Healthcare Recent Developments/Updates
  7.7.6 Ge Healthcare Competitive Strengths & Weaknesses
7.8 PERKINELMER
  7.8.1 PERKINELMER Details
  7.8.2 PERKINELMER Major Business
  7.8.3 PERKINELMER Newborn Genetic Screening Product and Services
  7.8.4 PERKINELMER Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 PERKINELMER Recent Developments/Updates
  7.8.6 PERKINELMER Competitive Strengths & Weaknesses
7.9 Natus Medical Incorporated
  7.9.1 Natus Medical Incorporated Details
  7.9.2 Natus Medical Incorporated Major Business
  7.9.3 Natus Medical Incorporated Newborn Genetic Screening Product and Services
  7.9.4 Natus Medical Incorporated Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Natus Medical Incorporated Recent Developments/Updates
  7.9.6 Natus Medical Incorporated Competitive Strengths & Weaknesses
7.10 Waters
  7.10.1 Waters Details
  7.10.2 Waters Major Business
  7.10.3 Waters Newborn Genetic Screening Product and Services
  7.10.4 Waters Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Waters Recent Developments/Updates
  7.10.6 Waters Competitive Strengths & Weaknesses
7.11 Bio-Rad Laboratories
  7.11.1 Bio-Rad Laboratories Details
  7.11.2 Bio-Rad Laboratories Major Business
  7.11.3 Bio-Rad Laboratories Newborn Genetic Screening Product and Services
  7.11.4 Bio-Rad Laboratories Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Bio-Rad Laboratories Recent Developments/Updates
  7.11.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.12 Ab Sciex LLC
  7.12.1 Ab Sciex LLC Details
  7.12.2 Ab Sciex LLC Major Business
  7.12.3 Ab Sciex LLC Newborn Genetic Screening Product and Services
  7.12.4 Ab Sciex LLC Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 Ab Sciex LLC Recent Developments/Updates
  7.12.6 Ab Sciex LLC Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Newborn Genetic Screening Industry Chain
8.2 Newborn Genetic Screening Upstream Analysis
8.3 Newborn Genetic Screening Midstream Analysis
8.4 Newborn Genetic Screening Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Newborn Genetic Screening Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Newborn Genetic Screening Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Newborn Genetic Screening Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Newborn Genetic Screening Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Newborn Genetic Screening Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Newborn Genetic Screening Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Newborn Genetic Screening Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Newborn Genetic Screening Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Newborn Genetic Screening Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Newborn Genetic Screening Players in 2022
Table 12. World Newborn Genetic Screening Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Newborn Genetic Screening Company Evaluation Quadrant
Table 14. Head Office of Key Newborn Genetic Screening Player
Table 15. Newborn Genetic Screening Market: Company Product Type Footprint
Table 16. Newborn Genetic Screening Market: Company Product Application Footprint
Table 17. Newborn Genetic Screening Mergers & Acquisitions Activity
Table 18. United States VS China Newborn Genetic Screening Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Newborn Genetic Screening Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Newborn Genetic Screening Companies, Headquarters (States, Country)
Table 21. United States Based Companies Newborn Genetic Screening Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Newborn Genetic Screening Revenue Market Share (2018-2023)
Table 23. China Based Newborn Genetic Screening Companies, Headquarters (Province, Country)
Table 24. China Based Companies Newborn Genetic Screening Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Newborn Genetic Screening Revenue Market Share (2018-2023)
Table 26. Rest of World Based Newborn Genetic Screening Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Newborn Genetic Screening Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Newborn Genetic Screening Revenue Market Share (2018-2023)
Table 29. World Newborn Genetic Screening Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Newborn Genetic Screening Market Size by Type (2018-2023) & (USD Million)
Table 31. World Newborn Genetic Screening Market Size by Type (2024-2029) & (USD Million)
Table 32. World Newborn Genetic Screening Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Newborn Genetic Screening Market Size by Application (2018-2023) & (USD Million)
Table 34. World Newborn Genetic Screening Market Size by Application (2024-2029) & (USD Million)
Table 35. Trivitron Healthcare Basic Information, Area Served and Competitors
Table 36. Trivitron Healthcare Major Business
Table 37. Trivitron Healthcare Newborn Genetic Screening Product and Services
Table 38. Trivitron Healthcare Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Trivitron Healthcare Recent Developments/Updates
Table 40. Trivitron Healthcare Competitive Strengths & Weaknesses
Table 41. MASIMO CORPORATION Basic Information, Area Served and Competitors
Table 42. MASIMO CORPORATION Major Business
Table 43. MASIMO CORPORATION Newborn Genetic Screening Product and Services
Table 44. MASIMO CORPORATION Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. MASIMO CORPORATION Recent Developments/Updates
Table 46. MASIMO CORPORATION Competitive Strengths & Weaknesses
Table 47. Covidien Plc Basic Information, Area Served and Competitors
Table 48. Covidien Plc Major Business
Table 49. Covidien Plc Newborn Genetic Screening Product and Services
Table 50. Covidien Plc Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Covidien Plc Recent Developments/Updates
Table 52. Covidien Plc Competitive Strengths & Weaknesses
Table 53. Nemours KidsHealth Basic Information, Area Served and Competitors
Table 54. Nemours KidsHealth Major Business
Table 55. Nemours KidsHealth Newborn Genetic Screening Product and Services
Table 56. Nemours KidsHealth Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Nemours KidsHealth Recent Developments/Updates
Table 58. Nemours KidsHealth Competitive Strengths & Weaknesses
Table 59. NJ.gov Basic Information, Area Served and Competitors
Table 60. NJ.gov Major Business
Table 61. NJ.gov Newborn Genetic Screening Product and Services
Table 62. NJ.gov Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. NJ.gov Recent Developments/Updates
Table 64. NJ.gov Competitive Strengths & Weaknesses
Table 65. Agilent Technologies Basic Information, Area Served and Competitors
Table 66. Agilent Technologies Major Business
Table 67. Agilent Technologies Newborn Genetic Screening Product and Services
Table 68. Agilent Technologies Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Agilent Technologies Recent Developments/Updates
Table 70. Agilent Technologies Competitive Strengths & Weaknesses
Table 71. Ge Healthcare Basic Information, Area Served and Competitors
Table 72. Ge Healthcare Major Business
Table 73. Ge Healthcare Newborn Genetic Screening Product and Services
Table 74. Ge Healthcare Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Ge Healthcare Recent Developments/Updates
Table 76. Ge Healthcare Competitive Strengths & Weaknesses
Table 77. PERKINELMER Basic Information, Area Served and Competitors
Table 78. PERKINELMER Major Business
Table 79. PERKINELMER Newborn Genetic Screening Product and Services
Table 80. PERKINELMER Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. PERKINELMER Recent Developments/Updates
Table 82. PERKINELMER Competitive Strengths & Weaknesses
Table 83. Natus Medical Incorporated Basic Information, Area Served and Competitors
Table 84. Natus Medical Incorporated Major Business
Table 85. Natus Medical Incorporated Newborn Genetic Screening Product and Services
Table 86. Natus Medical Incorporated Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Natus Medical Incorporated Recent Developments/Updates
Table 88. Natus Medical Incorporated Competitive Strengths & Weaknesses
Table 89. Waters Basic Information, Area Served and Competitors
Table 90. Waters Major Business
Table 91. Waters Newborn Genetic Screening Product and Services
Table 92. Waters Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Waters Recent Developments/Updates
Table 94. Waters Competitive Strengths & Weaknesses
Table 95. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 96. Bio-Rad Laboratories Major Business
Table 97. Bio-Rad Laboratories Newborn Genetic Screening Product and Services
Table 98. Bio-Rad Laboratories Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bio-Rad Laboratories Recent Developments/Updates
Table 100. Ab Sciex LLC Basic Information, Area Served and Competitors
Table 101. Ab Sciex LLC Major Business
Table 102. Ab Sciex LLC Newborn Genetic Screening Product and Services
Table 103. Ab Sciex LLC Newborn Genetic Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Newborn Genetic Screening Upstream (Raw Materials)
Table 105. Newborn Genetic Screening Typical Customers

LIST OF FIGURES

Figure 1. Newborn Genetic Screening Picture
Figure 2. World Newborn Genetic Screening Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Newborn Genetic Screening Total Market Size (2018-2029) & (USD Million)
Figure 4. World Newborn Genetic Screening Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Newborn Genetic Screening Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Newborn Genetic Screening Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Newborn Genetic Screening Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Newborn Genetic Screening Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Newborn Genetic Screening Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Newborn Genetic Screening Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Newborn Genetic Screening Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Newborn Genetic Screening Revenue (2018-2029) & (USD Million)
Figure 13. Newborn Genetic Screening Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)
Figure 16. World Newborn Genetic Screening Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)
Figure 18. China Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)
Figure 23. India Newborn Genetic Screening Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Newborn Genetic Screening by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Newborn Genetic Screening Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Newborn Genetic Screening Markets in 2022
Figure 27. United States VS China: Newborn Genetic Screening Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Newborn Genetic Screening Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Newborn Genetic Screening Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Newborn Genetic Screening Market Size Market Share by Type in 2022
Figure 31. Dry blood spot tests
Figure 32. Hearing screening tests
Figure 33. CCHD screening tests
Figure 34. World Newborn Genetic Screening Market Size Market Share by Type (2018-2029)
Figure 35. World Newborn Genetic Screening Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Newborn Genetic Screening Market Size Market Share by Application in 2022
Figure 37. Clinical Laboratories
Figure 38. Hospitals
Figure 39. Newborn Genetic Screening Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source


More Publications